Publications by authors named "Imran Rafique"

Claim this Profile
P
Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non-small cell lung cancer.
Ahmad A Tarhini, Imran Rafique, Theofanis Floros, Phu Tran, William E Gooding

Cancer· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint blockade and interferon-α in melanoma.
Imran Rafique, John M Kirkwood, Ahmad A Tarhini

Semin Oncol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis